scispace - formally typeset
D

David N. Finegold

Researcher at University of Pittsburgh

Publications -  97
Citations -  9278

David N. Finegold is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lymphedema & Gene. The author has an hindex of 43, co-authored 93 publications receiving 8569 citations. Previous affiliations of David N. Finegold include Boston Children's Hospital & Indira Gandhi Centre for Atomic Research.

Papers
More filters
Journal ArticleDOI

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

TL;DR: It is found that isolated human primary lymphatic and blood vascular endothelial cells show interesting differences in gene expression relevant for their distinct functions in vivo, and overexpression of the homeobox transcription factor Prox‐1 in the BECs is suggested to act as a cell proliferation inducer and a fate determination factor for the LECs.
Journal ArticleDOI

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

TL;DR: It is established that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGfr-3 signal transduction are a cause of primary lymphoedema.
Journal ArticleDOI

A model for gene therapy of human hereditary lymphedema

TL;DR: By using virus-mediated VEGF-C gene therapy, the results suggest that growth factor gene therapy is applicable to human lymphedema and provide a paradigm for other diseases associated with mutant receptors.
Journal ArticleDOI

Photonic Crystal Carbohydrate Sensors: Low Ionic Strength Sugar Sensing

TL;DR: A carbohydrate sensing material, which consists of a crystalline colloidal array (CCA) incorporated into a polyacrylamide hydrogel with pendent boronic acid groups, which responds to species containing vicinal cis diols such as carbohydrates.